十味清瘟汤调控TLR4/NF-κB通路与NLRP3炎症小体减轻LPS诱导的急性肺损伤
十味清瘟汤(SWQ)源于经典方玉屏风散,临床对早期肺炎有防治效果但机制不明。本研究通过HPLC分析成分,在LPS诱导的ALI大鼠模型和THP-1细胞炎症模型中验证,发现SWQ可减轻肺损伤、降低炎症介质,其机制与抑制TLR4/NF-κB信号通路和NLRP3炎症小体活化有关。
要点
- SWQ减轻LPS诱导的ALI大鼠肺水肿和组织病理损伤。
- SWQ下调BALF白细胞和中性粒细胞计数及炎症因子表达。
- SWQ通过抑制TLR4/NF-κB通路和NLRP3炎症小体发挥抗炎作用。
核心结论
- 十味清瘟汤通过抑制TLR4/NF-κB信号通路和NLRP3炎症小体活化,减轻LPS诱导的急性肺损伤炎症反应。
研究设计与样本
- 研究采用HPLC初步确定SWQ化学成分,并在LPS诱导的ALI大鼠模型(SWQ剂量3.27、6.55、13.1 g/kg)中评估效果,结合网络药理学预测通路,最后通过大鼠ALI模型和THP-1细胞炎症模型验证分子机制。
主要发现
- HPLC鉴定出SWQ含绿原酸、prime-O-glucosylcimifugin、毛蕊异黄酮和5-O-methylaminoside。
- SWQ减轻ALI大鼠肺湿/干重比(W/D)并防止肺组织病理损伤。
- SWQ上调AQP1、AQP5和eNOS,减少炎症介质渗透。
- SWQ预处理下调BALF中白细胞和中性粒细胞计数,抑制LPS诱导的MPO、NE及促炎因子(TNF-α、IL-1β、IL-6、iNOS)表达。
- 网络药理学显示SWQ与TLR4/NF-κB炎症通路相关;体内外实验证实SWQ降低TLR4、Myd88、p-IκB、p-p65及NLRP3、ASC、caspase-1、cleaved-IL-1β表达。
临床怎么用
- 十味清瘟汤基于玉屏风散,临床用于预防和治疗早期肺炎,本研究为其抗炎机制提供实验依据。
- 对于LPS相关急性肺损伤,SWQ可能通过调控TLR4/NF-κB和NLRP3炎症小体途径减轻炎症,但需临床研究验证。
局限性
- 研究仅基于LPS诱导的ALI大鼠模型和THP-1细胞模型,尚未在人体中验证。
- SWQ的化学成分与药效物质基础需进一步明确,最佳剂量和安全性未在临床中评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Shiwei Qingwen decoction (SWQ), a Chinese herbal formula based on the classic traditional Chinese medicine prescription Yu Ping Feng San, has shown efficacy in preventing and treating early pneumonia with good clinical outcomes. However, its underlying mechanism is yet unclear. AIM OF THE STUDY: To clarify the preventive and therapeutic effects of SWQ on lipopolysaccharide (LPS)-induced acute lung injury (ALI) and explore the underlying mechanism by which SWQ influences pneumonia. MATERIALS AND METHODS: First, the chemical composition of SWQ was preliminarily determined by high performance liquid chromatography (HPLC), and the impact of SWQ (3.27, 6.55, and 13.1 g/kg) was assessed in the LPS-induced ALI rat model. Next, its inflammatory pathway was determined via network pharmacology. Finally, the molecular mechanism of SWQ was validated using a rat ALI model and a THP-1 cell inflammation model. RESULTS: HPLC identified chlorogenic acid, prime-O-glucosylcimifugin, calycosin, and 5-O-methylaminoside in the chemical profile of SWQ. In the ALI model, SWQ alleviated ALI by reducing lung wet/dry weight ratio (W/D) and preventing histopathological damage to the lungs. At the same time, SWQ decreased penetration of inflammatory mediators by upregulating AQP1 and AQP5 and endothelial nitric oxide synthase (eNOS). Pretreatment with SWQ downregulated white blood cells and neutrophils count in BALF and suppressed LPS-induced expression levels of MPO, NE, and pro-inflammatory factors (TNF-α, IL-1β, IL-6, and iNOS). Network pharmacology showed that SWQ was associated with TLR4/NF-κB inflammation pathway. Moreover, pretreatment with SWQ reduced the expression level of TLR4/NF-κB signaling pathway-associated proteins (TLR4, Myd88, p-IκB, and p-p65) and NLRP3 inflammasome (NLRP3, ASC, caspase-1, and cleaved-IL-1β) in vivo and vitro. CONCLUSIONS: The present study demonstrates that SWQ can reduce inflammation in ALI by inhibiting TLR4/NF-κB and NLRP3 inflammasome activation.
引用
- Zhang Q, Yang C, Ma S, et al. Shiwei Qingwen decoction regulates TLR4/NF-κB signaling pathway and NLRP3 inflammasome to reduce inflammatory response in lipopolysaccharide-induced acute lung injury. J Ethnopharmacol. 2023. PMID: 37164255. doi:10.1016/j.jep.2023.116615
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。